BioSpace News Archive

Esteemed molecular pathologist to accelerate the use of real-world data for life sciences and health systems product and service development

InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral regurgitation, announced today the appointment of veteran medical device executive J. Brent Ratz to the role of Chief Executive Officer of the company and executive member of the Board of Directors.

Nanotronics today announced the formation of Nanotronics Health, LLC, a healthcare technology company whose mission is to create urgently needed medical devices that are accessible, affordable, easy to use, and intelligently designed.

Surfaces contaminated with Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, pose a threat to the safety of healthcare providers, schools, office workers, and essential businesses, who face the risk of contracting COVID-19 in their workplace

ASH published new guidelines to help older adults with acute myeloid leukemia and their health care providers make critical care decisions, including if and how to proceed with cancer treatment and the need for blood transfusions for those in hospice care.

BioLife Plasma Services, part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, today announced the opening of a new plasma collection center in Baton Rouge to collect standard plasma from healthy donors.

ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd today announced a clinical collaboration and exclusive license agreement for ImmVira’s MVR-T3011 intratumoral oncolytic virus program for the commercialization of novel immunotherapies to treat solid malignant tumors. ImmVira’s MVR-T3011 onco

At their August 5 meeting, the Board of Education celebrated the Battelle National Biodefense Institute’s award to Frederick County Public Schools of $50,000 for science, technology, engineering and math challenge grants. During a 6-week open competition, teachers from elementary, middle and high schools developed and submitted 16 STEM grant proposals. Of the 16, nine were selected as winners. Each of the 9 selected p

Levo Therapeutics, Inc., a biotechnology company dedicated to using genetic insights to advance treatments for Prader-Willi syndrome (PWS) and related disorders, announced today top-line results from the Phase 3 CARE-PWS clinical study evaluating LV-101 (intranasal carbetocin) for the treatment of PWS. This syndrome is a complex, neurodevelopmental disorder that occurs in approximately 1 in 16,000 births i and is characterized b

Yield10 Bioscience, Inc. (NASDAQ: YTEN), an agricultural bioscience company, announced today that the Company will report its second quarter 2020 financial results and provide a corporate update on Tuesday, August 11, 2020. Management will host a conference call on Tuesday, August 11, 2020 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update. Following management’s formal remarks, ther